# G5-RNA-Seq

## Supplementary Resource to:

Karn T et al. A small hypoxia signature predicted pCR response to bevacizumab in the neoadjuvant GeparQuinto breast cancer trial. Clinical Cancer Research, Published OnlineFirst January 13, 2020
[doi: 10.1158/1078-0432.CCR-19-1954](http://clincancerres.aacrjournals.org/cgi/content/abstract/1078-0432.CCR-19-1954)

*Pubmed:*

[https://www.ncbi.nlm.nih.gov/pubmed/?term=](https://www.ncbi.nlm.nih.gov/pubmed/?term=)

************************************************************

## This resource contains the following data described in the paper:

* [< Signature_GeneList.xlsx >](https://github.com/tkarn/G5-RNA-Seq/blob/master/Signature_GeneList.xlsx)

    Excel file containing gene list of 268 individual genes of metagene clusters from Figure 1 (corresponding to Suppl.Table S4)

* [< Fig1_data.cdt >](https://github.com/tkarn/G5-RNA-Seq/blob/master/Fig1_data.cdt)

    RNA-Seq expression data corresponding to Main Figure 1 in cdt-format for TreeView program

* [< SuppTables.pdf >](https://github.com/tkarn/G5-RNA-Seq/blob/master/SuppTables.pdf)

    Supplementary Tables S1 - S8

    
* [< SuppFig-S1.pdf >](https://github.com/tkarn/G5-RNA-Seq/blob/master/SuppFig-S1.pdf)

    Supplementary Figure S1:  CONSORT-Diagram of the flow of samples through the study
    
* [< SuppFig-S2.pdf >](https://github.com/tkarn/G5-RNA-Seq/blob/master/SuppFig-S2.pdf)

    Supplementary Figure S2: Detailed strategy of the immunohistochemical validation of hypoxia signature
    
* [< SuppFig-S3.pdf >](https://github.com/tkarn/G5-RNA-Seq/blob/master/SuppFig-S3.pdf)

    Supplementary Figure S3: Correlation of Affymetrix microarray expression data and IHC scoring of three genes in independent TNBC dataset

* [< SuppFig-S4.pdf >](https://github.com/tkarn/G5-RNA-Seq/blob/master/SuppFig-S4.pdf)

    Supplementary Figure S4: IHC of NDRG1 showing para-necrotic expression in TNBC

* [< SuppFig-S5.pdf >](https://github.com/tkarn/G5-RNA-Seq/blob/master/SuppFig-S5.pdf)

    Supplementary Figure S5: Heatmaps showing the comparison of signature detection in high quality and low quality samples

* [< SuppFig-S6.pdf >](https://github.com/tkarn/G5-RNA-Seq/blob/master/SuppFig-S6.pdf)

    Supplementary Figure S6: Box-plot demonstrating the correlation of proliferation signature and histological grade

* [< SuppFig-S7.pdf >](https://github.com/tkarn/G5-RNA-Seq/blob/master/SuppFig-S7.pdf)

    Supplementary Figure S7: Scatter plot of NDRG1-IHC on tissue microarray vs RNA-Seq from core samples demonstrating the poor detection of NDRG1 expression signal in TMA analysis
    
* [< SuppFig-S8.pdf >](https://github.com/tkarn/G5-RNA-Seq/blob/master/SuppFig-S8.pdf)

    Supplementary Figure S8: Box-plots of hypoxia signature from RNA-Seq and clinical response by treatment arm
    

 
